InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Berkman Charles S, Vice-Président Senior, Conseiller Général et Secrétaire. Officer active across 3 companies, notably Ligand Pharmaceuticals INC. Aggregated, 27 filings have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €43k. Activity tracked since 26 January 2022. The latest transaction was filed on 7 April 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Berkman Charles S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报27 总计
7,157 股@ US$1.498.6% 占其流量Common StockSEC:0001628280-26-024131:1
13,542 股0Common StockSEC:0001628280-26-024131:0
18,750 股0Common StockSEC:0001392266-26-000002:0
13,542 股0Common StockSEC:0001628280-26-008704:0
15,621 股0Common StockSEC:0001392266-25-000006:0
13,542 股0Common StockSEC:0001628280-25-016991:0
15,615 股Common StockSEC:0001846253-25-000012:0
45,294 股0Common StockSEC:0001846253-25-000006:0
15,621 股Common StockSEC:0001846253-24-000099:0
366,511 股Common StockSEC:0001846253-24-000012:0
6,954 股@ US$5.2731.7% 占其流量Common StockSEC:0002001011-24-000044:1
13,541 股Common StockSEC:0002001011-24-000044:0
15,624 股Common StockSEC:0002001011-24-000020:0
17,556 股Common StockSEC:0002001011-24-000004:0
15,622 股Common StockSEC:0002001011-23-000008:0
40,625 股0Common StockSEC:0001846253-23-000041:0
1,973 股@ US$3.806.6% 占其流量Common StockSEC:0001846253-23-000016:0
46,864 股0Common StockSEC:0000899243-23-001020:0
6,518 股@ US$3.6621.1% 占其流量Common StockSEC:0000899243-22-039582:0
10,580 股@ US$3.3532.0% 占其流量Common StockSEC:0000899243-22-037744:0
15,409 股0Common StockSEC:0000899243-22-035045:0
353,716 股Common StockSEC:0000899243-22-035063:0
11,944 股Common StockSEC:0000899243-22-035038:0
5,375 股0Common StockSEC:0000886163-22-000093:0
368 股@ US$123.68100.0% 占其流量Common StockSEC:0000886163-22-000024:0
27 条申报中的 25 条
About Berkman Charles S
Berkman Charles S is Senior Vice President, General Counsel and Secretary. He has 27 filings in total. In the sampled recent filings from 2016-02-16 to 2026-04-07, sales total 42859 EUR and the most frequent transaction nature is option exercise. His listed companies are OmniAb, Inc., Ligand Pharmaceuticals INC and OmniAb Operations, Inc.
